Literature DB >> 8702829

Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity.

D Rusciano1, P Lorenzoni, M M Burger.   

Abstract

Serial selection in vivo for liver colonization of B16 murine melanoma cells consistently resulted in cell lines expressing elevated amounts of the hepatocyte growth factor/scatter factor receptor (c-Met), which is constitutively activated in the absence of its cognate ligand. In this paper we present evidence suggesting that c-Met constitutive activation in liver-specific B16 melanoma cells depends on both receptor concentration on the cell surface and a cytosolic tyrosine phosphatase activity. In fact, c-Met constitutive activation is suddenly lost upon detachment of the cells from the substrate and is dramatically decreased in adherent cells plated at low density. The loss of tyrosine phosphorylation of c-Met in suspension appears to depend, at least partly, on an increased cytosolic tyrosine phosphatase activity. Instead, lower activation of c-Met at low density mostly results from a decrease in receptor concentration on the membrane. Moreover, we show that c-Met activation does not occur homogeneously on the surface of adherent cells. In fact, receptor concentration and activation appear to be higher on the ventral surface (adherent to the substrate) than on the apical surface. Upon detachment, compartmentalization is lost, leading to a decrease in average receptor density on the plasma membrane and hence to a lower activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702829     DOI: 10.1074/jbc.271.34.20763

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Differential expression of RAB5A in human lung adenocarcinoma cells with different metastasis potential.

Authors:  L Yu; F Hui-chen; Y Chen; R Zou; S Yan; L Chun-xiang; W Wu-ru; P Li
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

Review 2.  Dysregulation of Met receptor tyrosine kinase activity in invasive tumors.

Authors:  Alla Danilkovitch-Miagkova; Berton Zbar
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

3.  C-met activation is necessary but not sufficient for liver colonization by B16 murine melanoma cells.

Authors:  S Lin; D Rusciano; P Lorenzoni; G Hartmann; W Birchmeier; S Giordano; P Comoglio; M M Burger
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

4.  Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival.

Authors:  L Moro; M Venturino; C Bozzo; L Silengo; F Altruda; L Beguinot; G Tarone; P Defilippi
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

5.  Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.

Authors:  Z Wu; U Cavallaro; P C Marchisio; M R Soria; J A Maier
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

6.  P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading.

Authors:  Paola Di Stefano; Sara Cabodi; Elisabetta Boeri Erba; Valentina Margaria; Elena Bergatto; Maria Gabriella Giuffrida; Lorenzo Silengo; Guido Tarone; Emilia Turco; Paola Defilippi
Journal:  Mol Biol Cell       Date:  2003-12-02       Impact factor: 4.138

7.  Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.

Authors:  A K Mitra; K Sawada; P Tiwari; K Mui; K Gwin; E Lengyel
Journal:  Oncogene       Date:  2010-11-29       Impact factor: 9.867

8.  Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice.

Authors:  R Wang; L D Ferrell; S Faouzi; J J Maher; J M Bishop
Journal:  J Cell Biol       Date:  2001-05-28       Impact factor: 10.539

Review 9.  MET targeting: time for a rematch.

Authors:  Jonas P Koch; Daniel M Aebersold; Yitzhak Zimmer; Michaela Medová
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

10.  Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture.

Authors:  J D Bergström; A Hermansson; T Diaz de Ståhl; N E Heldin
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.